Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
By P. Staats, T. Yearwood, S. Charapata, R. Presley, M. Wallace, M. Byas‐Smith, R. Fisher, D. Bryce, Eugene A Mangieri, R. Luther and 3 more. Journal of the American Medical Association (JAMA), 2004
613 citations recorded by the source corpus.
Subfields: Anesthesiology and Pain Medicine, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/190b2a75cc57758ba657b031f3b9610d372c9329
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Anesthesiology and Pain Medicine
In Public Health, Environmental and Occupational Health
Citations in the corpus
- The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential (2015, background): “, 2002) and human patients with persistent cancer pain (Atanassoff et al., 2000; Miljanich, 2004; Staats et al., 2004; Thompson et al., 2006; Wallace et al., 2006; Ver Donck et al., 2008).”
- Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. (2007, background): “Staats et al (1290) in a multicenter, double-blind trial, reported that a neuron-specific calcium channel blocker delivered via an implanted intrathecal pump in patients with cancer and AIDS-related pain syndromes significantly decreased pain scores in 51% of the patients compared to 1 % in the plac”